Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 349

1.

Temporal trends in prenatal risk factors for the development of infantile hemangiomas.

Schoch JJ, Hunjan MK, Anderson KR, Lohse CM, Hand JL, Davis DMR, Tollefson MM.

Pediatr Dermatol. 2018 Sep 6. doi: 10.1111/pde.13659. [Epub ahead of print]

PMID:
30187967
2.

Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1.

Walwyn-Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald AS, Davis DM.

J Immunol. 2018 Oct 1;201(7):2028-2041. doi: 10.4049/jimmunol.1800475. Epub 2018 Aug 17.

PMID:
30120122
3.

Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells.

Srpan K, Ambrose A, Karampatzakis A, Saeed M, Cartwright ANR, Guldevall K, De Matos GDSC, Önfelt B, Davis DM.

J Cell Biol. 2018 Sep 3;217(9):3267-3283. doi: 10.1083/jcb.201712085. Epub 2018 Jul 2.

4.

How studying the immune system leads us to new medicines.

Davis DM.

Lancet. 2018 Jun 2;391(10136):2205-2206. doi: 10.1016/S0140-6736(18)31166-8. Epub 2018 May 24. No abstract available.

PMID:
29804630
5.

A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency.

Tordo J, O'Leary C, Antunes ASLM, Palomar N, Aldrin-Kirk P, Basche M, Bennett A, D'Souza Z, Gleitz H, Godwin A, Holley RJ, Parker H, Liao AY, Rouse P, Youshani AS, Dridi L, Martins C, Levade T, Stacey KB, Davis DM, Dyer A, Clément N, Björklund T, Ali RR, Agbandje-McKenna M, Rahim AA, Pshezhetsky A, Waddington SN, Linden RM, Bigger BW, Henckaerts E.

Brain. 2018 Jul 1;141(7):2014-2031. doi: 10.1093/brain/awy126.

6.

Activation of Human Natural Killer Cells by Graphene Oxide-Templated Antibody Nanoclusters.

Loftus C, Saeed M, Davis DM, Dunlop IE.

Nano Lett. 2018 May 9;18(5):3282-3289. doi: 10.1021/acs.nanolett.8b01089. Epub 2018 Apr 20.

7.

A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner.

Bálint Š, Lopes FB, Davis DM.

Sci Signal. 2018 Apr 10;11(525). pii: eaal3606. doi: 10.1126/scisignal.aal3606.

PMID:
29636390
8.
9.

Nanoscale Dynamism of Actin Enables Secretory Function in Cytolytic Cells.

Carisey AF, Mace EM, Saeed MB, Davis DM, Orange JS.

Curr Biol. 2018 Feb 19;28(4):489-502.e9. doi: 10.1016/j.cub.2017.12.044. Epub 2018 Feb 1.

10.

Tinea capitis mimicking dissecting cellulitis in three children.

Shastry J, Ciliberto H, Davis DM.

Pediatr Dermatol. 2018 Jan;35(1):e79-e83. doi: 10.1111/pde.13343. Epub 2017 Dec 18.

PMID:
29265536
11.

Association between atopic dermatitis and squamous cell carcinoma: a case-control study.

Cho JM, Davis DMR, Wetter DA, Bartley AC, Brewer JD.

Int J Dermatol. 2018 Mar;57(3):313-316. doi: 10.1111/ijd.13857. Epub 2017 Dec 15.

PMID:
29243817
12.

An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.

Gil-Krzewska A, Saeed MB, Oszmiana A, Fischer ER, Lagrue K, Gahl WA, Introne WJ, Coligan JE, Davis DM, Krzewski K.

J Allergy Clin Immunol. 2018 Sep;142(3):914-927.e6. doi: 10.1016/j.jaci.2017.10.040. Epub 2017 Dec 11.

13.

The effect of 1.5 T cardiac magnetic resonance on human circulating leucocytes.

Critchley WR, Reid A, Morris J, Naish JH, Stone JP, Ball AL, Major T, Clark D, Waldron N, Fortune C, Lagan J, Lewis GA, Ainslie M, Schelbert EB, Davis DM, Schmitt M, Fildes JE, Miller CA.

Eur Heart J. 2018 Jan 21;39(4):305-312. doi: 10.1093/eurheartj/ehx646.

PMID:
29165554
14.

Orthopedic complications of linear morphea: Implications for early interdisciplinary care.

Schoch JJ, Schoch BS, Werthel JD, McIntosh AL, Davis DMR.

Pediatr Dermatol. 2018 Jan;35(1):43-46. doi: 10.1111/pde.13336. Epub 2017 Nov 9.

PMID:
29119592
15.

When Does the Knee Feel Normal Again: A Cross-Sectional Study Assessing the Forgotten Joint Score in Patients After Total Knee Arthroplasty.

Carlson VR, Post ZD, Orozco FR, Davis DM, Lutz RW, Ong AC.

J Arthroplasty. 2018 Mar;33(3):700-703. doi: 10.1016/j.arth.2017.09.063. Epub 2017 Oct 7.

PMID:
29108793
16.

Atopic dermatitis: phototherapy and systemic therapy.

Davis DM, Borok J, Udkoff J, Lio P, Spergel J.

Semin Cutan Med Surg. 2017 Sep;36(3):118-123. doi: 10.12788/j.sder.2017.027.

PMID:
28895958
17.

Atopic dermatitis: addressing allergy, infection, itch and complementary therapies.

Ahluwalia J, Davis DM, Jacob S, Waldman A, Ong PY, Cohen S, Friedman A, Lio P, Jetter N, Bienstock J, LeBovidge J, Spergel J, Fonacier L.

Semin Cutan Med Surg. 2017 Sep;36(3):112-117. doi: 10.12788/j.sder.2017.038.

PMID:
28895957
18.

Diagnosis, comorbidity, and psychosocial impact of atopic dermatitis.

Davis DM, Waldman A, Jacob S, LeBovidge J, Ahluwalia J, Tollefson M, Jetter N, Spergel J.

Semin Cutan Med Surg. 2017 Sep;36(3):95-99. doi: 10.12788/j.sder.2017.028.

PMID:
28895954
19.

Curriculum United for Better Eczema Care: why, how, and what?

Eichenfield LF, Ahluwalia J, Davis DM, Fleischer DM, Waldman A, Spergel J.

Semin Cutan Med Surg. 2017 Sep;36(3):93-94. doi: 10.12788/j.sder.2017.033.

PMID:
28895953
20.

Type I interferon is required for T helper (Th) 2 induction by dendritic cells.

Webb LM, Lundie RJ, Borger JG, Brown SL, Connor LM, Cartwright AN, Dougall AM, Wilbers RH, Cook PC, Jackson-Jones LH, Phythian-Adams AT, Johansson C, Davis DM, Dewals BG, Ronchese F, MacDonald AS.

EMBO J. 2017 Aug 15;36(16):2404-2418. doi: 10.15252/embj.201695345. Epub 2017 Jul 17.

21.

Missed diagnoses in African Americans with obsessive-compulsive disorder: the structured clinical interview for DSM-IV Axis I disorders (SCID-I).

Chasson GS, Williams MT, Davis DM, Combs JY.

BMC Psychiatry. 2017 Jul 17;17(1):258. doi: 10.1186/s12888-017-1422-z.

22.

Associations of self-reported allergic diseases and musculoskeletal problems in children: A US population-based study.

Barrick BJ, Jalan S, Tollefson MM, Milbrandt TA, Larson AN, Rank MA, Lohse CM, Davis DMR.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):170-176. doi: 10.1016/j.anai.2017.06.002. Epub 2017 Jun 28.

PMID:
28668547
23.

Distinct Effects of Dexamethasone on Human Natural Killer Cell Responses Dependent on Cytokines.

Morgan DJ, Davis DM.

Front Immunol. 2017 Apr 13;8:432. doi: 10.3389/fimmu.2017.00432. eCollection 2017.

24.

Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages.

Lopes FB, Bálint Š, Valvo S, Felce JH, Hessel EM, Dustin ML, Davis DM.

J Cell Biol. 2017 Apr 3;216(4):1123-1141. doi: 10.1083/jcb.201608094. Epub 2017 Mar 13.

25.

Prenatal Risk Factors for Infantile Hemangioma Development.

Hunjan MK, Schoch JJ, Anderson KR, Lohse CM, Marnach ML, Hand JL, Davis DMR, Tollefson MM.

J Invest Dermatol. 2017 Apr;137(4):954-957. doi: 10.1016/j.jid.2016.10.047. Epub 2016 Dec 7. No abstract available.

26.

Patient experiences of acute myeloid leukemia: A qualitative study about diagnosis, illness understanding, and treatment decision-making.

LeBlanc TW, Fish LJ, Bloom CT, El-Jawahri A, Davis DM, Locke SC, Steinhauser KE, Pollak KI.

Psychooncology. 2017 Dec;26(12):2063-2068. doi: 10.1002/pon.4309. Epub 2016 Dec 19.

PMID:
27862591
27.

Pediatric Pyoderma Gangrenosum: A Retrospective Review of Clinical Features, Etiologic Associations, and Treatment.

Schoch JJ, Tolkachjov SN, Cappel JA, Gibson LE, Davis DM.

Pediatr Dermatol. 2017 Jan;34(1):39-45. doi: 10.1111/pde.12990. Epub 2016 Oct 4.

PMID:
27699861
28.

Acceptance and Use of Protective Stabilization Devices by Pediatric Dentistry Diplomates in the United States.

Davis DM, Fadavi S, Kaste LM, Vergotine R, Rada R.

J Dent Child (Chic). 2016;83(2):60-6.

PMID:
27620515
29.

Leukocytoclastic vasculitis in children: clinical characteristics, subtypes, causes and direct immunofluorescence findings of 56 biopsy-confirmed cases.

Johnson EF, Wetter DA, Lehman JS, Hand JL, Davis DM, Tollefson MM.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):544-549. doi: 10.1111/jdv.13952. Epub 2016 Sep 19.

PMID:
27580419
30.

Successful Treatment of Keratosis Pilaris Rubra with Pulsed Dye Laser.

Schoch JJ, Tollefson MM, Witman P, Davis DM.

Pediatr Dermatol. 2016 Jul;33(4):443-6. doi: 10.1111/pde.12892. Epub 2016 Jun 10.

PMID:
27282957
31.

The Size of Activating and Inhibitory Killer Ig-like Receptor Nanoclusters Is Controlled by the Transmembrane Sequence and Affects Signaling.

Oszmiana A, Williamson DJ, Cordoba SP, Morgan DJ, Kennedy PR, Stacey K, Davis DM.

Cell Rep. 2016 May 31;15(9):1957-72. doi: 10.1016/j.celrep.2016.04.075. Epub 2016 May 19.

32.

Integrating spatially explicit indices of abundance and habitat quality: an applied example for greater sage-grouse management.

Coates PS, Casazza ML, Ricca MA, Brussee BE, Blomberg EJ, Gustafson KB, Overton CT, Davis DM, Niell LE, Espinosa SP, Gardner SC, Delehanty DJ.

J Appl Ecol. 2016 Feb;53(1):83-95. Epub 2015 Nov 27.

33.

Penile and Scrotal Swelling: An Underrecognized Presentation of Crohn's Disease.

Barrick BJ, Tollefson MM, Schoch JJ, McEvoy MT, Hand JL, Wieland CN, Davis DM.

Pediatr Dermatol. 2016 Mar-Apr;33(2):172-7. doi: 10.1111/pde.12772. Epub 2016 Jan 14.

PMID:
26764123
34.

Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight.

Anderson KR, Schoch JJ, Lohse CM, Hand JL, Davis DM, Tollefson MM.

J Am Acad Dermatol. 2016 Jan;74(1):120-6. doi: 10.1016/j.jaad.2015.08.024. Epub 2015 Oct 19.

35.

Incidence of Melanoma in Children: A Population-Based Study in Olmsted County, Minnesota.

Lowe GC, Brewer JD, Peters MS, Davis DM.

Pediatr Dermatol. 2015 Sep-Oct;32(5):618-20. doi: 10.1111/pde.12621. Epub 2015 Jun 8.

36.

Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds.

Lagrue K, Carisey A, Morgan DJ, Chopra R, Davis DM.

Blood. 2015 Jul 2;126(1):50-60. doi: 10.1182/blood-2015-01-625004. Epub 2015 May 22.

37.

Cutaneous manifestations of pediatric granulomatosis with polyangiitis: a clinicopathologic and immunopathologic analysis.

Wright AC, Gibson LE, Davis DM.

J Am Acad Dermatol. 2015 May;72(5):859-67. doi: 10.1016/j.jaad.2015.01.043. Epub 2015 Mar 5.

PMID:
25748311
38.

Corrigendum: The immune synapse clears and excludes molecules above a size threshold.

Cartwright AN, Griggs J, Davis DM.

Nat Commun. 2015 Mar 6;6:6109. doi: 10.1038/ncomms7109. No abstract available.

39.

The immune synapse clears and excludes molecules above a size threshold.

Cartwright AN, Griggs J, Davis DM.

Nat Commun. 2014 Nov 19;5:5479. doi: 10.1038/ncomms6479. Erratum in: Nat Commun. 2015;6:6109.

40.

Cultural adaptations of prolonged exposure therapy for treatment and prevention of posttraumatic stress disorder in african americans.

Williams MT, Malcoun E, Sawyer BA, Davis DM, Bahojb Nouri L, Bruce SL.

Behav Sci (Basel). 2014 May 14;4(2):102-24. doi: 10.3390/bs4020102. eCollection 2014 Jun.

41.

Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.

Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Eichenfield LF.

J Am Acad Dermatol. 2014 Dec;71(6):1218-33. doi: 10.1016/j.jaad.2014.08.038. Epub 2014 Sep 26.

42.

Computational analysis of signaling patterns in single cells.

Davis DM, Purvis JE.

Semin Cell Dev Biol. 2015 Jan;37:35-43. doi: 10.1016/j.semcdb.2014.09.015. Epub 2014 Sep 26. Review.

43.

Expanded level of sympathetic chain removal does not increase the incidence or severity of compensatory hyperhidrosis after endoscopic thoracic sympathectomy.

Gunn TM, Davis DM, Speicher JE, Rossi NP, Parekh KR, Lynch WR, Iannettoni MD.

J Thorac Cardiovasc Surg. 2014 Dec;148(6):2673-6. doi: 10.1016/j.jtcvs.2014.06.080. Epub 2014 Jul 22.

44.

Brief report: serpin Spi2A as a novel modulator of hematopoietic progenitor cell formation.

Li L, Byrne SM, Rainville N, Su S, Jachimowicz E, Aucher A, Davis DM, Ashton-Rickardt PG, Wojchowski DM.

Stem Cells. 2014 Sep;32(9):2550-6. doi: 10.1002/stem.1778.

45.

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R.

J Am Acad Dermatol. 2014 Jul;71(1):116-32. doi: 10.1016/j.jaad.2014.03.023. Epub 2014 May 9.

46.

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Simpson EL, Tom WL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Eichenfield LF; American Academy of Dermatology.

J Am Acad Dermatol. 2014 Aug;71(2):327-49. doi: 10.1016/j.jaad.2014.03.030. Epub 2014 May 9.

47.

Presenting the marvels of immunity.

Davis DM.

Nat Rev Immunol. 2014 Jun;14(6):351-3. doi: 10.1038/nri3681. Epub 2014 Apr 28. No abstract available.

PMID:
24769836
48.

Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity.

Castleton A, Dey A, Beaton B, Patel B, Aucher A, Davis DM, Fielding AK.

Blood. 2014 Feb 27;123(9):1327-35. doi: 10.1182/blood-2013-09-528851. Epub 2013 Dec 17.

49.

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R.

J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27. Review.

50.

Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology.

Horner ME, Alikhan A, Tintle S, Tortorelli S, Davis DM, Hand JL.

Int J Dermatol. 2013 Dec;52(12):1464-80. doi: 10.1111/ijd.12305. Review.

PMID:
24261722

Supplemental Content

Loading ...
Support Center